Analysts expect Inovio Pharmaceuticals, Inc. to report revenue of 52,636.50 for Q4 26, against a range of 49,114.17 to 56,158.83. The most recent reported quarter, Q3 26, came in at 298,900.00.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 117,000.00 | 65,340.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 298,900.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 41,809.80 | 12,417.27 | 11,000.89 | 0.00 | 0.00 | 345,683.50 | 0.00 | 0.00 | 56,158.83 | 6.50 M | 17.56 M | 35.61 M | 22.44 M | 28.05 M | 33.35 M | 55.37 M | |||||||||
| Low Estimate | 35,720.20 | 11,011.35 | 9,657.51 | 0.00 | 0.00 | 305,100.00 | 0.00 | 0.00 | 49,114.17 | 5.32 M | 14.49 M | 29.25 M | 20.00 M | 23.91 M | 27.73 M | 48.60 M | |||||||||
| Consensus Estimate | 38,765.00 | 11,714.31 | 10,329.20 | 0.00 | 0.00 | 325,391.75 | 0.00 | 0.00 | 52,636.50 | 5.91 M | 16.03 M | 32.43 M | 21.22 M | 25.98 M | 30.54 M | 51.98 M |
Analysts expect Inovio Pharmaceuticals, Inc. to report earnings per share of -0.13 for Q4 26, against a range of -0.14 to -0.12. The most recent reported quarter, Q3 26, came in at -0.50, a 150.0% miss against the -0.20 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.65 | -0.51 | -0.61 | -0.87 | 0.06 | -0.28 | -0.07 | -0.50 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.74 | -0.59 | -0.61 | -0.37 | -0.36 | -0.31 | -0.22 | -0.19 | -0.12 | -0.10 | -0.06 | 0.01 | 0.34 | -0.11 | -0.12 | -0.14 | |||||||||
| Low Estimate | -0.86 | -0.71 | -0.67 | -0.43 | -0.40 | -0.37 | -0.24 | -0.21 | -0.14 | -0.10 | -0.06 | 0.01 | 0.32 | -0.13 | -0.12 | -0.16 | |||||||||
| Consensus Estimate | -0.80 | -0.65 | -0.64 | -0.40 | -0.38 | -0.34 | -0.23 | -0.20 | -0.13 | -0.10 | -0.06 | 0.01 | 0.33 | -0.12 | -0.12 | -0.15 |
Pull Wall Street consensus for Inovio Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INO&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=INO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();